PITTSBURGH, Dec. 13 /PRNewswire/ -- The Pittsburgh Life Sciences Greenhouse (PLSG), the organization providing capital investments and customized company formation and business growth services to the region's life sciences enterprises, announced that the PLSG has invested $100,000 in ParentPlus. ParentPlus was formed to commercialize innovative and proprietary human fertility technologies and provide subfertile couples worldwide better odds of fulfilling their dream to start a family. Subfertility affects couples, not individuals, and 75 million couples are impacted world-wide. Of these, only 56% seek treatment and a mere 22 % get treatment.
ParentPlus is positioning its initial product, FertPlus(R), to increase the efficacy of fertility treatments and at the same time provide a lower cost alternative to expensive and highly publicized conventional treatments.
The PLSG's $100,000 investment will help ParentPlus develop FertPlus(R) and conduct a sufficiently-sized medical school study to compare binding of sperm exposed to hPSF with a control. The resulting data will be used to prepare for a pre-trial conference with the Food and Drug Administration (FDA) to obtain clearance to market. After clearance by the FDA, FPSPM can be introduced to fertility clinics as the medium used in sperm preparation for IntraUterine Insemination (IUI) treatment.
"Currently there is no other treatment available to enhance the success
of IUI," said John W. Manzetti, President & CEO of the PLSG. "The
ParentPlus technology will provide couples with a reduced number of
insemination attempts, which helps alleviate the financial and emotional
stress associated with subfertility." Mr. Manzetti continued, "There are
currently no FDA- approved pro-fertility products acting on human sperm.
The development and success of ParentPlus' product will be the first such
medium with significant potential to increase the probability of couples
becoming pregnant and can ultimately
|SOURCE Pittsburgh Life Sciences Greenhouse|
Copyright©2007 PR Newswire.
All rights reserved